Join
Live feed
·
PRReleasevia Quantisnow
Crinetics Pharmaceuticals Inc. logo

Crinetics Submits New Drug Application for Paltusotine for the Treatment of Acromegaly

ByQuantisnow·Wall Street's wire, on your screen.
CRNX· Crinetics Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CRNX (Crinetics Pharmaceuticals Inc.) and more on Quantisnow.